The Diagnosis and Treatment of Hepatopulmonary Syndrome

Clinics in Liver Disease

Volumn 10, Issue 2, 2006, Pages 387-405

  Mandell, M Susan ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; NONHUMAN; ORGAN DONOR; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PROGNOSIS; REVIEW; SYMPTOMATOLOGY; TREATMENT INDICATION;

HEPATOPULMONARY SYNDROME; HUMANS; LIVER TRANSPLANTATION; PORTASYSTEMIC SHUNT, SURGICAL; PULMONARY CIRCULATION;

EID: 33846260289     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2006.05.007     Document Type: Review

References (61)

1. Berthelot P., Walker J.G., Sherlock S., et al. Arterial changes in the lungs of cirrhosis of the liver-lung spider nevi. N Engl J Med 274 6 (1966) 291-298
2. Wolfe J.D., Tashkin D.P., Holly F.E., et al. Hypoxemia of cirrhosis. Detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method. Am J Med 63 5 (1977) 746-774
3. Van Thiel D., Schade R., Gavaler J., et al. Medical aspects of liver transplantation. Hepatology 4 1 Suppl (1984) 79-83
4. Wiesner R., Edwards R., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124 1 (2003) 91-96
5. Krowka M., and Cortese D. Hepatopulmonary syndrome: current concepts in diagnosis and therapeutic considerations. Chest 105 5 (1994) 1528-1537
6. Agusti A., Roca J., and Rodriguez-Roizen R. Mechanisms of gas exchange impairment in patients with liver cirrhosis. Clin Chest Med 17 1 (1996) 49-66
7. Kim B.J., Lee S.C., Park S.W., et al. Characteristics and prevalence of intrapulmonary shunt detected by contrast echocardiography with harmonic imaging in liver transplant candidates. Am J Cardiol 94 4 (2004) 525-528
8. Castaing Y., and Manier G. Hemodynamic disturbances and VA/Q matching in hypoxemic cirrhotic patients. Chest 96 5 (1989) 1064-1069
9. Mandell M.S. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era. Liver Transpl 10 Suppl 2 (2004) S54-S58
10. Schenk P.M., Fuhrmann V., Madl C., et al. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 51 6 (2002) 853-859
11. Thorens J.B., and Junod A.F. Hypoxemia and liver cirrhosis: a new argument in favor of a "diffusion-perfusion defect". Eur Respir J 5 6 (1992) 754-756
12. Katsuta Y., Honma H., Zhang X.J., et al. Pulmonary blood transit time and impaired arterial oxygenation in patients with chronic liver disease. J Gastroenterol 40 1 (2005) 57-63
13. Rodriguez-Roisin R., Roca J., Agusti A.G., et al. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 135 5 (1987) 1085-1092
14. Aller R., Moreira V., Boixeda D., et al. Diagnosis of hepatopulmonary syndrome with contrast transthoracic echocardiography and histological confirmation. Liver 18 4 (1998) 285-287
15. Mimdis K.P., Karatza C., Spiropoulos K.V., et al. Prevalence of intrapulmonary vascular dilatations in normoxaemic patients with early cirrhosis. Scand J Gastroenterol 33 9 (1998) 988-992
16. Ruff F. Effect of age and posture on closing volume. Scand J Respir Dis Suppl 85 (1974) 190-200
17. Gomez F.P., Martinez-Pali G., Barbera J.A., et al. Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology 40 3 (2004) 660-666
18. Rea H.H., Withy S.J., Seelye E.R., et al. The effects of posture on venous admixture and respiratory dead space in health. Am Rev Respir Dis 115 4 (1977) 571-580
19. Krowka M.J., and Cortese D.A. Severe hypoxemia associated with liver disease. Mayo Clin Proc 62 3 (1987) 164-173
20. Ferry T.G., and Naum C.C. Orthodeoxia-platypnea due to diabetic autonomic neuropathy. Diabetes Care 22 5 (1999) 857-859
21. Guerin P., Lambert V., Godart F., et al. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: results of a multicentric French registry. Cardiovasc Intervent Radiol 28 2 (2005) 164-168
22. Bourke S.J., Munro N.C., White J.E., et al. Platypnoea-orthodeoxia in cryptogenic fibrosing alveolitis. Respir Med 89 5 (1995) 387-389
23. Nagata T., Matsumoto A., Uehara Y., et al. Oxygenation abnormalities in normoxemic patients with mild liver cirrhosis. Intern Med 41 6 (2002) 435-440
24. Edell E.S., Cortese D.A., Krowka M.J., et al. Severe hypoxemia and liver disease. Am Rev Respir Dis 140 6 (1989) 1631-1635
25. Chang S.W., and Ohara N. Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model of the hepatopulmonary syndrome. Am Rev Respir Dis 145 4 Pt 1 (1992) 798-805
26. Rockey D.C., Fouassier L., Chung J.J., et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology 27 1 (1998) 472-480
27. Luo B., Abrams G.A., and Fallon M.B. Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol 29 (1998) 571-578
28. Luo B., Liu L., Tang L., et al. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats; a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 38 5 (2003) 556-563
29. Hirata Y., Emori T., Eguchi S., et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 91 4 (1993) 1367-1373
30. Zhang H.Y., Han D.W., Wang X.G., et al. Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. World J Gastroenterol 11 4 (2005) 567-572
31. Fallon M.B. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome. J Clin Gastroenterol 39 4 (2005) S138-S142
32. 1-antitrypsin deficiency, primary biliary cirrhosis, chronic hepatitis C and other hepatic problems. Clin Chest Med 17 1 (1996) 67-82
33. Abrams G.A., Jaffe C.C., Hoffer P.B., et al. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 109 4 (1995) 1283-1288
34. Lange P., and Stoller J. The hepatopulmonary syndrome. Ann Intern Med 122 7 (1995) 521-529
35. Eldridge M., Dempsey J., Haverkamp H., et al. Exercise-induced intrapulmonary arteriovenous shunting in healthy humans. J Appl Physiol 97 3 (2004) 797-805
36. Schraufnagel D., and Kay J. Structural and pathological changes in the lung vasculature in chronic liver disease. Clin Chest Med 17 1 (1996) 1-15
37. Abrams G.A., Nanda N.C., Dubovsky E.V., et al. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 114 2 (1998) 305-310
38. Arguedas M., Abrams G., Krowka M., et al. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 37 1 (2003) 192-197
39. Egawa H., Kasahara M., Inomata Y., et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 67 5 (1999) 712-717
40. Collisson E.A., Nourmand H., Fraiman M., et al. Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl 8 10 (2002) 925-931
41. Martinez G.P., Barbera J.A., Visa J., et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 34 5 (2001) 651-657
42. Stickland MK, Welsch RC, Haykowsky MJ, et al. Intrapulmonary shunt and pulmonary gas exchange during exercise. J Physiol 2004;561:(Pt1)321-9.
43. Luo B., Tang L., Wang Z., et al. Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. Gastroenterology 129 2 (2005) 6826-6895
44. Taille C., Cadranel J., Bellocq A., et al. Liver transplantation for hepatopulmonary syndrome. A ten-year experience in Paris, France. Transplantation 75 5 (2003) 1482-1489
45. Schenk P., Fuhrmann V., Madl C., et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125 4 (2003) 1042-1052
46. United Network for Organ Sharing. Policy 3.6.5.4.1 Liver candidates with hepatopulmonary syndrome. Available at: http://www.unos.org/policies and bylaws/policies/doc. Accessed May 2, 2004.
47. Organ Procurement and Transplantation Network. Health Resources and Services Administration, Health and Human Services. Final rule. Fed Regist 64 202 (1999) 56650-56661
48. 99m Tc MAA lung scanning. Chest 18 3 (2000) 615-624
49. Krowka M.J., Mandell M.S., Ramsay M.A., et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 10 2 (2004) 174-182
50. Swanson K.L., Wiesner R.H., and Krowka M.J. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 41 5 (2005) 112-119
51. Lasch H.M., Fried M.W., Zacks S.L., et al. Use of transjugular intrahepatic portosystemic shunts as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome. Liver Transpl 7 2 (2001) 147-149
52. Chevallier P., Noveli L., Motamedi J.P., et al. Hepatopulmonary syndrome successfully treated with transjugular intrahepatic portosystemic shunt: a three-year followup. Vasc Interv Radiol 15 6 (2004) 647-648
53. Selim K.M., Akriviadis E.A., Zuckerman E., et al. Transjugular intrahepatic portosystemic shunt: a successful treatment for portopulmonary hypertension. Am J Gastroenterol 93 3 (1998) 455-458
54. Sztrymf B., Libert J.M., Mougeot C., et al. Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome. J Gastroenterol Hepatol 20 10 (2005) 1538-1544
55. Rabiller A., Nunes H., Lebrec D., et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 166 4 (2002) 514-517
56. Sztrymf B., Rabiller A., Nunes H., et al. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Repir J 23 5 (2004) 752-758
57. Brussino L., Bucca C., Morello M., et al. Effect on dyspnoea and hypoxaemia of inhaled N (G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome. Lancet 362 9377 (2003) 43-44
58. Jounieaux V., Leleu O., and Mayeux I. Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome. Intensive Care Med 27 6 (2001) 1103-1104
59. Taniai N., Onda M., Tajiri T., et al. Reversal of hypoxemia by inhaled nitric oxide in a child with hepatopulmonary syndrome after living-related transplantation. Transpl Proc 34 7 (2002) 2791-2792
60. Poterucha J.J., Krowka M.J., Dickson E.R., et al. Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology 21 1 (1995) 96-100
61. Ryu J.K., and Oh J.H. Hepatopulmonary syndrome: angiography and therapeutic embolization. Clin Imaging 27 2 (2003) 97-100